Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 19 | 0 | 0 | 19 |
ATAD5 protein, partial | 6 | 0 | 0 | 6 |
GLS protein | 7 | 0 | 0 | 7 |
Microtubule-associated protein tau | 6 | 0 | 0 | 6 |
Smad3 | 5 | 0 | 0 | 5 |
aldehyde dehydrogenase 1 family, member A1 | 14 | 0 | 0 | 14 |
thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
nuclear receptor subfamily 1, group I, member 3 | 17 | 0 | 0 | 17 |
progesterone receptor | 14 | 0 | 0 | 14 |
EWS/FLI fusion protein | 10 | 0 | 0 | 11 |
retinoic acid nuclear receptor alpha variant 1 | 19 | 0 | 0 | 19 |
retinoid X nuclear receptor alpha | 15 | 0 | 0 | 15 |
estrogen-related nuclear receptor alpha | 21 | 0 | 0 | 21 |
estrogen nuclear receptor alpha | 27 | 0 | 0 | 27 |
peroxisome proliferator activated receptor gamma | 13 | 0 | 0 | 13 |
aryl hydrocarbon receptor | 11 | 0 | 0 | 11 |
chromobox protein homolog 1 | 10 | 0 | 0 | 10 |
thyroid hormone receptor beta isoform 2 | 18 | 0 | 0 | 18 |
peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit pi | 7 | 0 | 0 | 7 |
ATP-binding cassette sub-family C member 3 | 0 | 10 | 0 | 10 |
Multidrug resistance-associated protein 4 | 0 | 10 | 0 | 11 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 3 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 3 | 0 | 3 |
Voltage-dependent calcium channel gamma-2 subunit | 13 | 0 | 0 | 13 |
Bile salt export pump | 0 | 15 | 0 | 15 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 4 | 0 | 6 |
Carbonic anhydrase 2 | 0 | 4 | 0 | 7 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 6 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 3 |
Cytochrome P450 3A4 | 0 | 3 | 1 | 4 |
Cytochrome P450 2D6 | 0 | 3 | 0 | 3 |
Cytochrome P450 2C9 | 0 | 5 | 0 | 5 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 0 | 0 | 7 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 0 | 0 | 7 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 2 |
Glutamate receptor 2 | 13 | 0 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 0 | 0 | 7 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 3 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 0 | 0 | 7 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 5 | 1 | 7 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 3 |
Nuclear receptor ROR-gamma | 8 | 0 | 0 | 8 |
Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 0 | 0 | 7 |
Carbonic anhydrase 9 | 0 | 2 | 0 | 3 |
GABA theta subunit | 7 | 0 | 0 | 7 |
Canalicular multispecific organic anion transporter 1 | 0 | 10 | 0 | 10 |
Carbonic anhydrase 15 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit epsilon | 7 | 0 | 0 | 7 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 3 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
Luciferase | 9 | 0 | 0 | 9 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
acetylcholinesterase | 4 | 0 | 0 | 4 |
glp-1 receptor, partial | 4 | 0 | 0 | 4 |
hypoxia-inducible factor 1 alpha subunit | 7 | 0 | 0 | 7 |
SMAD family member 2 | 9 | 0 | 0 | 9 |
SMAD family member 3 | 9 | 0 | 0 | 9 |
GLI family zinc finger 3 | 16 | 0 | 0 | 16 |
AR protein | 19 | 0 | 0 | 19 |
apical membrane antigen 1, AMA1 | 4 | 0 | 0 | 4 |
caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
estrogen receptor 2 (ER beta) | 10 | 0 | 0 | 10 |
glucocorticoid receptor [Homo sapiens] | 13 | 0 | 0 | 13 |
farnesoid X nuclear receptor | 10 | 0 | 0 | 10 |
pregnane X nuclear receptor | 13 | 0 | 0 | 13 |
peroxisome proliferator-activated receptor delta | 12 | 0 | 0 | 12 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 10 | 0 | 0 | 10 |
caspase-3 | 3 | 0 | 0 | 3 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 10 | 0 | 0 | 10 |
activating transcription factor 6 | 8 | 0 | 0 | 8 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 9 | 0 | 0 | 9 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 10 | 0 | 0 | 10 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 5 | 0 | 0 | 5 |
heat shock protein beta-1 | 4 | 0 | 0 | 4 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 17 | 0 | 0 | 17 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 7 | 0 | 0 | 7 |
geminin | 17 | 0 | 0 | 17 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 2 | 0 | 0 | 2 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 16 | 0 | 0 | 16 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Aryl hydrocarbon receptor | 0 | 0 | 1 | 1 |
thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
interleukin 8 | 6 | 0 | 0 | 6 |
pregnane X receptor | 5 | 0 | 0 | 5 |
TDP1 protein | 15 | 0 | 0 | 15 |
bromodomain adjacent to zinc finger domain 2B | 6 | 0 | 0 | 6 |
arylsulfatase A | 6 | 0 | 0 | 6 |
IDH1 | 5 | 0 | 0 | 5 |
euchromatic histone-lysine N-methyltransferase 2 | 14 | 0 | 0 | 14 |
nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
cellular tumor antigen p53 isoform a | 5 | 0 | 0 | 5 |
Nuclear hormone receptor family member daf-12 | 0 | 0 | 1 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 4 | 0 | 0 | 4 |
oxysterols receptor LXR-beta isoform 1 | 0 | 0 | 1 | 1 |
urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
plasminogen precursor | 4 | 0 | 0 | 4 |
urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
survival motor neuron protein isoform d | 8 | 0 | 0 | 8 |
muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
Thymidine kinase, cytosolic | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Spike glycoprotein | 5 | 0 | 0 | 5 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 8 | 0 | 0 | 8 |
Ataxin-2 | 8 | 0 | 0 | 8 |
Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
Chain A, 2-oxoglutarate Oxygenase | 8 | 0 | 0 | 8 |
Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
Chain A, Cruzipain | 4 | 0 | 0 | 4 |
DNA topoisomerase | 0 | 1 | 0 | 1 |
thioredoxin reductase | 10 | 0 | 0 | 10 |
15-lipoxygenase, partial | 5 | 0 | 0 | 5 |
Fumarate hydratase | 3 | 0 | 0 | 3 |
NFKB1 protein, partial | 4 | 0 | 0 | 4 |
PPM1D protein | 3 | 0 | 0 | 3 |
Thrombopoietin | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
regulator of G-protein signaling 4 | 6 | 0 | 0 | 6 |
polyprotein | 3 | 0 | 0 | 3 |
67.9K protein | 4 | 0 | 0 | 4 |
glucocerebrosidase | 4 | 0 | 0 | 4 |
putative alpha-glucosidase | 1 | 0 | 0 | 1 |
alpha-galactosidase | 2 | 0 | 0 | 2 |
Bloom syndrome protein isoform 1 | 5 | 0 | 0 | 5 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
hemoglobin subunit beta | 3 | 0 | 0 | 3 |
cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 6 | 0 | 0 | 6 |
huntingtin isoform 2 | 4 | 0 | 0 | 4 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
eukaryotic translation initiation factor 2-alpha kinase 3 isoform 1 precursor | 0 | 0 | 1 | 1 |
nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
M-phase phosphoprotein 8 | 5 | 0 | 0 | 5 |
muscleblind-like protein 1 isoform 1 | 5 | 0 | 0 | 5 |
histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 3 | 0 | 0 | 3 |
lamin isoform A-delta10 | 11 | 0 | 0 | 11 |
Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase Chk1 | 0 | 0 | 1 | 1 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
Type-2 restriction enzyme ScaI | 0 | 1 | 0 | 1 |
Deoxyribonuclease-2-alpha | 0 | 1 | 0 | 1 |
Tyrosyl-DNA phosphodiesterase 2 | 0 | 1 | 0 | 1 |
Deoxyribonuclease-1 | 0 | 1 | 0 | 1 |
Type-2 restriction enzyme PstI | 0 | 1 | 0 | 1 |
Type-2 restriction enzyme EcoRI | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 0 | 0 | 1 |
DNA ligase | 0 | 1 | 0 | 1 |
Interferon beta | 8 | 0 | 0 | 8 |
Integrin beta-3 | 2 | 0 | 0 | 2 |
Integrin alpha-IIb | 2 | 0 | 0 | 2 |
Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
DNA topoisomerase 1 | 0 | 1 | 1 | 6 |
DNA topoisomerase 2-alpha | 0 | 1 | 0 | 1 |
Type-2 restriction enzyme BamHI | 0 | 1 | 0 | 1 |
Somatostatin receptor type 1 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Type-2 restriction enzyme HindIII | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
DNA topoisomerase 2-beta | 0 | 0 | 0 | 1 |
DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
Histone deacetylase 1 | 0 | 3 | 0 | 3 |
DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Histone deacetylase 2 | 0 | 3 | 0 | 3 |
DNA topoisomerase type IB small subunit | 0 | 0 | 1 | 1 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Histone deacetylase 8 | 0 | 3 | 0 | 3 |
Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 2 | 0 | 2 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Histone H2A.x | 9 | 0 | 0 | 9 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 5 | 0 | 0 | 5 |
Nrf2 | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
USP1 protein, partial | 5 | 0 | 0 | 5 |
alkaline phosphatase, intestinal | 0 | 1 | 0 | 1 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
PINK1 | 1 | 0 | 0 | 1 |
Parkin | 3 | 0 | 0 | 3 |
toll-like receptor 9 | 0 | 1 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
TPA: protein transporter TIM10 | 0 | 1 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
perilipin-5 | 0 | 1 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 6 | 0 | 0 | 6 |
intestinal alkaline phosphatase precursor | 0 | 1 | 0 | 1 |
thyroid hormone receptor beta isoform a | 5 | 0 | 0 | 5 |
perilipin-1 | 0 | 1 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
pyruvate kinase PKM isoform a | 2 | 0 | 0 | 2 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 5 | 0 | 0 | 5 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
alkaline phosphatase, germ cell type preproprotein | 0 | 1 | 0 | 1 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
hypothetical protein SA1422 | 0 | 1 | 0 | 1 |
neuropeptide S receptor isoform A | 4 | 0 | 0 | 4 |
Prostaglandin E synthase | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 4 | 0 | 0 | 4 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Phospholipase A2 | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 2 | 0 | 2 |
Amyloid-beta precursor protein | 1 | 2 | 0 | 4 |
Neuronal proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Heme oxygenase 1 | 0 | 1 | 0 | 1 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Microtubule-associated protein tau | 0 | 1 | 0 | 2 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 2 | 0 | 2 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Heme oxygenase 2 | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
Alpha-synuclein | 2 | 1 | 1 | 4 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 7 | 0 | 1 | 8 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Beta-secretase 1 | 0 | 1 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Cholinesterase | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Lactoylglutathione lyase | 0 | 2 | 0 | 2 |
Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
Sodium/bile acid cotransporter | 0 | 0 | 1 | 1 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 1 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
Thioredoxin reductase 3 | 0 | 1 | 0 | 1 |
Sortase A | 0 | 1 | 0 | 1 |
CREB-binding protein | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 0 | 2 | 0 | 2 |
Cysteine protease | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
Thymidine kinase 2 | 0 | 1 | 0 | 1 |
Deoxycytidine kinase | 0 | 0 | 0 | 1 |
Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
Cytidine deaminase | 0 | 0 | 0 | 1 |
AAA family ATPase | 0 | 0 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 0 | 1 | 1 |
Hsf1 protein | 0 | 0 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 5 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 5 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
Prostacyclin receptor | 0 | 2 | 1 | 3 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 5 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 3 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 3 | 0 | 4 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
endonuclease IV | 3 | 0 | 0 | 3 |
Skn7p | 0 | 0 | 0 | 1 |
nonstructural protein 1 | 3 | 0 | 0 | 3 |
Vpr | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 1 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
ATP-dependent phosphofructokinase | 6 | 0 | 0 | 6 |
Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
Amino acid transporter | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
GALC protein | 2 | 0 | 0 | 2 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 2 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 0 | 1 | 2 | 3 |
Adenosine receptor A1 | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 2 |
Histamine H1 receptor | 0 | 1 | 2 | 3 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Histamine H1 receptor | 0 | 2 | 2 | 4 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 6 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 2 | 3 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 2 | 0 | 2 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 7 | 0 | 0 | 7 |
G | 5 | 0 | 0 | 5 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 3 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 5 | 0 | 0 | 5 |
Albumin | 0 | 2 | 3 | 5 |
Procathepsin L | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 6 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 2 | 2 | 4 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 5 | 0 | 0 | 5 |
Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
cytochrome P450 2C9, partial | 5 | 0 | 0 | 5 |
cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
ClpP | 1 | 0 | 0 | 1 |
Mcl-1 | 0 | 1 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
Bifunctional cytochrome P450/NADPH--P450 reductase | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
Bombesin receptor subtype-3 | 0 | 0 | 1 | 1 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 3 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Fatty acid synthase | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 2 | 0 | 0 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
WD repeat-containing protein 5 | 0 | 1 | 0 | 1 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase 2A | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Cytosolic endo-beta-N-acetylglucosaminidase | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 6 | 3 | 9 |
Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
Estrogen receptor | 0 | 3 | 1 | 4 |
Interleukin-5 | 0 | 1 | 0 | 1 |
Interleukin-5 | 0 | 1 | 0 | 1 |
Progesterone receptor | 0 | 3 | 1 | 4 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 3 | 1 | 5 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 4 | 0 | 5 |
Interleukin-5 receptor subunit alpha | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Estrogen receptor beta | 0 | 2 | 1 | 3 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 2 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Stromelysin-1 | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
Estrogen receptor | 0 | 0 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Protease | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |